These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Bleomycin in Hodgkin's disease (stages III and IV) and other lymphomas]. Pozzi D; Jamra M Rev Bras Pesqui Med Biol; 1975; 8(2):125-9. PubMed ID: 52169 [No Abstract] [Full Text] [Related]
5. When the patient is on bleomycin therapy. McMullen K Am J Nurs; 1975 Jun; 75(6):964-6. PubMed ID: 48341 [No Abstract] [Full Text] [Related]
6. Bleomycin: a clinical evaluation of the agent on its own or in combination with mitomycin C. van Dyk JJ; Falkson G; Falkson HC S Afr Med J; 1972 Dec; 46(49):1921-6. PubMed ID: 4120162 [No Abstract] [Full Text] [Related]
7. [Bleomycin: a new anti-tumor agent]. Thuot C; Poisson R; Perron L Union Med Can; 1972 May; 101(5):879-83. PubMed ID: 4125919 [No Abstract] [Full Text] [Related]
8. 'Flagellate' erythema from bleomycin. With histopathological findings suggestive of inflammatory oncotaxis. Cortina P; Garrido JA; Tomas JF; Unamuno P; Armijo M Dermatologica; 1990; 180(2):106-9. PubMed ID: 1690153 [TBL] [Abstract][Full Text] [Related]
9. [Anatomo- and cyto-pathological aspects of laryngeal cancers treated with bleomycin]. Marsan C; Trotoux J; Narcy P; de Saint-Macary M Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):185-201. PubMed ID: 4123907 [No Abstract] [Full Text] [Related]
10. [Assessment of a year's systematic use in cancer of the otorhinolaryngological area of a new antimitotic: bleomycin. Study of 209 patients]. Laccourreye H; De Saint Macary M; Narcy P; Trotoux J; Marsan C; Haguet JF; Soudant J Ann Otolaryngol Chir Cervicofac; 1972; 89(4):219-28. PubMed ID: 4116541 [No Abstract] [Full Text] [Related]
11. Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer. Moertel CG; Arena PJ; Schutt AJ; Reitemeir RJ; Hahn RG Cancer Chemother Rep; 1972 Apr; 56(2):207-10. PubMed ID: 4114486 [No Abstract] [Full Text] [Related]
12. [Bleomycin in advanced Hodgkin's disease]. Van Gijsegem D; Haemers J; Van Hove W Acta Clin Belg; 1977; 32(5):303-9. PubMed ID: 76385 [No Abstract] [Full Text] [Related]
13. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? Canellos GP; Duggan D; Johnson J; Niedzwiecki D J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636 [No Abstract] [Full Text] [Related]
15. Phase II evaluation of bleomycin. A Southwest oncology Group study. Haas CD; Coltman CA; Gottlieb JA; Haut A; Luce JK; Talley RW; Samal B; Wilson HE; Hoogstraten B Cancer; 1976 Jul; 38(1):8-12. PubMed ID: 59628 [TBL] [Abstract][Full Text] [Related]
16. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease. Real E; Roca MJ; ViƱuales A; Pastor E; Grau E Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918 [No Abstract] [Full Text] [Related]
17. [The J wave in the ECG as a sign of hypothermia]. Fink M; Jehn U; Schneider I MMW Munch Med Wochenschr; 1982 Apr; 124(15):381-2. PubMed ID: 6176862 [No Abstract] [Full Text] [Related]